1. Thailand Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Asian Phytoceuticals Public Co., Ltd. NVDR

Asian Phytoceuticals Public Co., Ltd. NVDR

2.50
THB
-0.02
(-0.79%)
0.10EPS
27.16P/E
1.54BMarket Cap
Asian Phytoceuticals Public Co., Ltd. NVDR
SET:APCO.R
(Stock Exchange of Thailand)

Recent

price

2.50

P/E

ratio

27.16

div

yld

3.56%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
THB
1.15
0.97
0.61
0.63
0.82
0.75
0.76
0.69
0.62
0.41
0.41
0.37
0.42
0.49
0.35
0.33
0.32
Revenue per Share
0.2
0.17
0.12
0.14
0.23
0.18
0.24
0.18
0.16
0.1
0.12
0.11
0.13
0.18
0.09
0.09
0.09
Basic EPS, GAAP
0.17
0.15
0.11
0.14
0.15
0.15
0.21
0.17
0.14
0.12
0.14
0.14
0.17
0.2
0.06
0.08
0.09
Free Cash Flow per Basic Share
0.14
0.17
0.11
0.1
0.08
0.21
0.17
0.22
0.18
0.15
0.09
0.12
0.12
0.15
0.18
0.09
0.09
Dividend per Share
0.42
0.62
0.64
0.68
0.88
0.96
1.08
1.05
1.02
0.97
0.99
0.99
1.01
1.02
0.93
0.93
0.89
Book Value per Share
0.42
0.62
0.64
0.68
0.87
0.96
1.08
1.05
1.02
0.96
0.99
0.99
1.01
1.01
0.93
0.93
0.89
Tangible Book Value per Share
223
300
472
551
520
547
554
600
592
600
600
600
600
601
608
616
613
Basic Weighted Avg Shares
256
291
286
349
426
409
421
416
370
248
248
223
250
293
211
200
197
Sales/Revenue/Turnover
23.11
24.54
25.2
29.9
34.74
29.11
31.19
29.53
29.78
26.48
30.49
33.05
35.16
39.93
25.19
27.96
28.9
Operating Margin (%)
7
6
8
8
9
16
17
14
14
14
31
27
23
22
21
20
19
Depreciation Expense
44
50
55
79
119
101
131
108
95
58
70
69
81
107
55
55
58
Net Income, GAAP
31.44
29.47
23.29
24.08
19.64
19.78
19.99
17.8
19.47
19.97
19.63
19.64
19.19
18.36
17.96
18.84
18.75
Effective Tax Rate (%)
17.31
17.25
19.27
22.62
27.89
24.59
31.19
26.03
25.62
23.38
28.25
30.76
32.32
36.72
25.95
27.68
29.39
Profit Margin (%)
124
302
290
312
406
424
545
536
532
513
192
183
192
255
377
398
386
Working Capital
2
1
- -
- -
- -
- -
- -
- -
- -
- -
32
15
2
22
11
2
1
LT Debt
186
372
380
404
515
568
649
628
614
579
595
595
611
612
560
560
537
Total Equity
- -
16.51
14.26
19.85
25.57
18.18
21.01
15.43
14
8.65
9.78
9.17
11.15
14.73
6.98
7.76
9.61
Return on Invested Capital (%)
- -
17.88
14.63
20.08
25.83
18.58
21.59
16.94
15.25
9.7
11.49
10.89
12.94
16.79
8.92
9.59
10.51
Return on Capital (%)
- -
17.99
14.67
20.11
25.84
18.58
21.59
16.94
15.25
9.7
11.91
11.54
13.45
17.66
9.38
9.95
10.95
Return on Common Equity (%)

Capital Structure

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
12
9
5
LT Borrowings
- -
- -
- -
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
600
600
600
Market Capitalization
1,716
1,656
1,536

Working Capital

THB

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
438
464
417
Cash, Cash Equivalents & STI
360
386
338
Accounts Receivable, Net
3
3
3
Inventories
69
73
74
Total Current Liabilities
40
43
31
Payables & Accruals
26
32
23
ST Debt
12
9
5
Deferred Revenue
- -
- -
- -

Growth Rates

THB

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.02%
-1.14%
0.08%
Free Cash Flow
2.57%
3.1%
45.09%
Net Income, GAAP
-1.65%
0.2%
1.28%
Sales/Revenue/Turnover
-5.63%
-2.77%
-5.06%
Total Cash Common Dividend
-2.91%
4.4%
-48.89%

Quarterly Revenue

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
55
54
54
48
211
2025
48
49
50
53
200
2026
50
44
- -
- -
- -

Quarterly Earnings Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.02
0.02
0.02
0.09
2025
0.02
0.02
0.02
0.02
0.09
2026
0.03
0.02
- -
- -
- -

Quarterly Dividends Per Share

THB

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.15
- -
- -
0.18
2025
- -
0.08
- -
- -
0.09
2026
- -
0.1
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Asian Phytoceuticals Public Company Limited, founded in 1988 and headquartered in Lamphun, Thailand, engages in the research, development, manufacturing, and distribution of natural extract-based beauty cosmetics and dietary supplements; its core products encompass slimming solutions, anti-wrinkle and anti-spots treatments, skin care and nourishing creams including Asian Life Revitalizing Serum and Cream, Garcinia Acne Cream, and Cleansing Cream, immunity-balancing items under Operation BIM such as Mylife, LIV Capsule, Arthrinox, Diabenok, Tumorid Capsule, Noriasis, and Canvirol, fat reduction and health drink formulations, as well as pet dietary supplements through subsidiary Killer T Cell for Pets Co., Ltd. The company operates primarily in Thailand via multi-channel marketing including sales agents, dropships, and Bim Health Centers in locations like Chiang Mai, Surat Thani, Chonburi, Ratchadapisek, and Esplanade, while exporting to international markets such as China, Hong Kong, Singapore, Malaysia, and the United States. Originally incorporated as Natural Cosmetics Research Company Limited, it became a public company in 2005, listed on the Market for Alternative Investment in 2011, and transitioned to the Stock Exchange of Thailand's main board in 2018 under the Consumer Products sector.